Evidence map›Paper›PMID 21521787›Full record

ArticleGenome research2011

Association studies for next-generation sequencing.

Li Luo, Eric Boerwinkle, Momiao Xiong

Abstract read
In one paragraph

Article in Genome research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Protein Sequencing, One Molecule at a Time.Annual review of biophysics · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li LuoHuman Genetics Center, University of Texas School of Public Health, Houston, TX 77030, USA.
Eric Boerwinkle
Momiao Xiong

Funding

The Genetic Basis of AS SusceptibilityP01AR052915 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI REVEILLE, JOHN DUFFIN · 2006 to 2016
$10.9M
Role of TGF-beta and CTGF Signaling Transgenic Mouse Models of SclerodermaP50AR054144 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CROMBRUGGHE, BENOIT DE · 2006 to 2010
$7.7M
Statistical Methods for Finding Missing HeritabilityR01HL106034 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2011 to 2014
$1.5M
Network Approach to GWA Studies of Rheumatoid Arthritis (RA), Ankylosing SpondyliR01AR057120 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI XIONG, MOMIAO · 2009 to 2010
$554k
NHLBI NIH HHS 1R01HL106034-01NHLBI NIH HHS R01 HL106034NIAMS NIH HHS 1R01AR057120-01NIAMS NIH HHS P01 AR052915NIAMS NIH HHS P01 AR052915-01A1NIAMS NIH HHS P50 AR054144NIAMS NIH HHS P50 AR054144-01NIAMS NIH HHS R01 AR057120
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) have become the primary approach for identifying genes with common variants influencing complex diseases. Despite considerable progress, the common variations identified by GWAS account for only a small fraction of disease heritability and are unlikely to explain the majority of phenotypic variations of common diseases. A potential source of the missing heritability is the contribution of rare variants. Next-generation sequencing technologies will detect millions of novel rare variants, but these technologies have three defining features: identification of a large number of rare variants, a high proportion of sequence errors, and a large proportion of missing data. These features raise challenges for testing the association of rare variants with phenotypes of interest. In this study, we use a genome continuum model and functional principal components as a general principle for developing novel and powerful association analysis methods designed for resequencing data. We use simulations to calculate the type I error rates and the power of nine alternative statistics: two functional principal component analysis (FPCA)-based statistics, the multivariate principal component analysis (MPCA)-based statistic, the weighted sum (WSS), the variable-threshold (VT) method, the generalized T(2), the collapsing method, the CMC method, and individual tests. We also examined the impact of sequence errors on their type I error rates. Finally, we apply the nine statistics to the published resequencing data set from ANGPTL4 in the Dallas Heart Study. We report that FPCA-based statistics have a higher power to detect association of rare variants and a stronger ability to filter sequence errors than the other seven methods.

Indexed as

Genetics, PopulationGenetic VariationModels, StatisticalAngiopoietin-Like Protein 4AngiopoietinsComputational BiologyComputer SimulationDatabases, GeneticGenome, HumanGenome-Wide Association StudyGenotypeHumansModels, BiologicalMultivariate AnalysisPhenotypeSequence Analysis, DNAAngiopoietin-Like Protein 4AngiopoietinsANGPTL4 protein, human

Identifiers

PMID21521787
PMCPMC3129252

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.